Screening for Cervical Cancer
Author(s) -
Patiyus Agustiansyah,
Rizal Sanif,
Siti Nurmaini,
Irfannuddin Irfannuddin,
Legiran
Publication year - 2021
Publication title -
bioscientia medicina journal of biomedicine and translational research
Language(s) - English
Resource type - Journals
ISSN - 2598-0580
DOI - 10.32539/bsm.v5i3.329
Subject(s) - disease , medicine , asymptomatic , cancer , stage (stratigraphy) , cancer screening , cervical cancer , screening test , public health , intervention (counseling) , intensive care medicine , pediatrics , pathology , psychiatry , biology , paleontology
Screening is a public health intervention administered to a target populationwithout symptoms. Screening is not performed to diagnose a disease, but toidentify individuals with a higher likelihood of developing the disease itself or aprecursor to the disease. Not all diseases are suitable for screening programs. Thefollowing criteria help determine whether a disease is suitable for a screeningprogram: (1) The disease is bound to have serious consequences. (2) The diseasemust have a detectable preclinical and asymptomatic stage. (3) Treatment at thepreclinical stage should influence the long-term course and prognosis of thedisease being screened. (4) Care must be available and accessible to those whohave a positive screening test. History, screening tests and treatment options forcervical pre-cancer meet these criteria.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom